Valiant Laboratories Ltd (VALIANTLAB) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Valiant Laboratories was originally formed as a partnership firm under the name and style of ‘M/s. Bharat Chemicals’ pursuant to the deed of partnership dated October 17, 1980, amended and restated from time to time. Subsequently, the partnership firm, M/s. Bharat Chemicals was converted into a public limited company under the provisions of the Companies Act with the name “Valiant Laboratories Limited” pursuant to certificate of incorporation dated August 16, 2021 issued by the by Central Registration Centre, Registrar of Companies. 

The company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. The company manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers. Paracetamol was initially approved by the U.S. Food and Drug Administration (USFDA) in 1951 and is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products.

The company was originally formed in year 1980 as a partnership firm under the Indian Partnership Act, 1932 under the name and style of ‘Bharat Chemicals’ and gradually, commenced manufacturing of Paracetamol by late 1982. In August 2021, its partnership firm was converted into a public limited company registered under the Companies Act. Its manufacturing facility is located at Plot nos. L-13 and L-30, Tarapur Industrial Area, Boisar, Palghar, in the state of Maharashtra, India. The company’s Manufacturing Facility employs modern machinery and equipment to ensure smooth flow of operations. It is holding certificate of good manufacturing practices (GMP) for manufacture and sale of bulk drugs / API and ISO 9001:2015 certification. Its quality control team monitors the manufacturing process at all stages from initial testing stage for incoming raw material to the final product prior to packing. 

Business area of the company

Valiant Laboratories is a leading Active Pharmaceutical ingredient manufacturing company with its focus on manufacturing Paracetamol API/Bulk Drug which has several applications like uses in treatment of conditions such as headache, muscle ache, arthritis, back ache, toothache, cold and fever. 

Product of the company

• Paracetamol/Acetaminophen

Key events and milestones

• 1980: Formed Bharat Chemicals (a partnership firm).
• 1981: Acquired plot No. L-30 in the Tarapur Industrial Area, Palghar, Maharashtra on leasehold basis admeasuring about 1,000 sq. mtrs.
• 1982: Commenced manufacture of Paracetamol.
• 2004-05: Acquired additional Plot Nos. L-28, L-28 (part), L-29 and L-13 at Tarapur Industrial Area, Palghar, Maharashtra collectively admeasuring about 3,000 sq. mtrs.
• 2015: Annual revenue from operations crossed Rs 500 million.
• 2021: Converted from partnership firm into a public limited company.
• 2021: Annual revenue from operations crossed Rs 1,000 million.
• 2022: Annual revenue from operations crossed Rs 2,000 million.
• 2022: Formed wholly owned subsidiary, VASPL to diversify business activities.
• 2023: The company got listed on BSE and NSE on October 6, 2023.
• 2025: Enhanced the manufacturing capacity of the Tarapur plant from 750 MT to 900 MT per month.